NFCR Writer David Perry, Author at NFCR

NFCR Writer David Perry

The Lucy Fund: Words of a Mother

Lucy Elicker Stanovick, an English professor, writer, wife and mother of two, received the news that she had Stage IV metastatic breast cancer in April 2008. Although active, health conscious and just 42 years old, she was faced suddenly with her mortality: Stage IV metastatic breast cancer cannot be cured,…...

Read more

Peter Vogt: The Game Changer

The term “game changer” didn’t come into English usage until 1993, and since then it has been driven into the ground from overuse. But when applied to Dr. Peter Vogt, it is more than just hyperbole or overzealous marketing. When you are talking about the person that identified src, the…...

Read more

September is Blood Cancer Awareness Month

To bring attention to leukemia and lymphoma, Congress in 2010 designated September as Blood Cancer Awareness Month. These diseases are diagnosed in 14,000 people monthly within the United States. But with advances in treatment and technologies yielding earlier and earlier detection, the overall five-year relative survival rate for leukemia has…...

Read more

Mark It Down: The Development of Better Ovarian Cancer Biomarkers

“The trouble with ultrasound is that it doesn’t detect many ovarian cancers early,” says Robert Bast, M.D., Vice President for Translational Research at MD Andersen Cancer Center in Houston. Moreover, “Ultrasound doesn’t see really small cancers in the ovary.”...

Read more

Pediatric Cancer Drug Has 93 Percent Effectiveness

A new cancer drug, larotrectinib, has in a very early clinical trial been shown to have a 93% (14/15) effectiveness rate for pediatric cancers; that is to say, for not just one cancer, but many. Hailed by the U.S. Food and Drug Administration as a “breakthrough therapy,” larotrectinib targets a…...

Read more

Cloud Atlas

It’s called “the cloud,” but it is not the fluffy white thingees drifting overhead. It promises to revolutionize cancer care. By, of all things, sharing data. “In cancer, only about 4% of patients go on a clinical trial, but that data is not ever really leveraged. The FDA (U.S. Food…...

Read more

Early Days, But New Compound May Prevent Metastasis

Oncologist Dr. Raymond Bergan and his team recently developed a drug compound that, in mouse models, seems to stave off metastasis—cancer spreading....

Read more

Oxidative Stress: The Role of Micronutrients in Battling Cancer

It was largely the work of Helmut Sies, M.D., the esteemed pioneer of oxidative stress whom the National Foundation for Cancer Research (NFCR) supported from 1983 to 2016, that brought the role of micronutrients, including flavonoids, into scientific focus....

Read more

Master Switch Metastasis Agent Identified

In a major breakthrough, scientists led by Elena Deryugina at The Scripps Research Institute (TSRI) identified a specific protein, Latent TGFβ Binding Protein 3—LTBP3 for short—that kicks off a cellular chain reaction resulting in early-development tumors growing new blood vessels. These vessels then act like highways to spread cancer cells…...

Read more

Frederick Alt: It’s Personal

Ask 100 physicians why they got into medicine and you’ll get 100 different answers: Some take the noble route and want to help people, others are just hardwired for it and still others learned early on that potential mates tend to worship doctors (or at least their mothers do!). And…...

Read more